aav-vector-design-agent
AAV vector design: capsid selection, promoter optimization, payload capacity.
Maintainer FreedomIntelligence · Last updated April 1, 2026
Construct and analyze compound-target-disease networks for drug repurposing, polypharmacology discovery, and systems pharmacology. Builds multi-layer networks from ChEMBL, OpenTargets, STRING, DrugBank, Reactome, FAERS, and 60+ other ToolUniverse tools. Calculates Network Pharmacology Scores (0-100), identifies repurposing candidates, predicts mechanisms, and analyzes polypharmacology. Use when users ask about drug….
Original source
https://github.com/FreedomIntelligence/OpenClaw-Medical-Skills/tree/main/skills/tooluniverse-network-pharmacology
Skill Snapshot
Source Doc
Apply when users:
NOT for (use other skills instead):
tooluniverse-drug-repurposingtooluniverse-drug-target-validationtooluniverse-adverse-event-detectiontooluniverse-disease-researchtooluniverse-gwas-snp-interpretation| Parameter | Required | Description | Example |
|---|---|---|---|
| entity | Yes | Compound name/ID, target gene symbol/ID, or disease name/ID | metformin, EGFR, Alzheimer disease |
| entity_type | No | Type hint: compound, target, or disease (auto-detected if omitted) | compound |
| analysis_mode | No | compound-to-disease, disease-to-compound, target-centric, bidirectional (default) | bidirectional |
| secondary_entity | No | Second entity for focused analysis (e.g., disease for compound input) | Alzheimer disease |
Related skills
AAV vector design: capsid selection, promoter optimization, payload capacity.
AgentD autonomous drug discovery: target identification, hit finding, ADMET optimization.
Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for tr…
Query PharmGKB and CPIC for drug-gene interactions, pharmacogenomic annotations, and dosing guidelines. Use when predicting drug response fr…